Focus on Psychosis
Page 3
Recently published articles about Focus on Psychosis
Original Research
Add-on Pramipexole for Schizophrenia
August 1, 2022
Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
Original Research
Effects of a Digital Medicine System on Psychiatric Hospitalization Rates for Adults With Schizophrenia
April 11, 2022
This clinical trial investigated whether hospitalization rates improved when patients with schizophrenia were treated via a digital medicine system (aripiprazole tablets with sensor) versus oral standard-of-care therapy.
Original Research
Prospective Memory Influences Social Functioning in First-Episode Schizophrenia
February 8, 2022
Prospective memory, or the ability to carry out an intended action in the future, is linked to social functioning in schizophrenia and is an important intervention target. This network...
Original Research
Patient Satisfaction With Antipsychotic Polypharmacy
December 21, 2021
Studies of antipsychotic polypharmacy (APP) tend to exclude the perspective of patients and how they experience treatment. This study examined satisfaction with pharmacologic treatment in patients who received APP...
Original Research
Lipid-Related Polygenic Effects Across the AD Spectrum
September 21, 2021
Lipid-related genes and serum lipids may affect cognitive function via regulating brain networks. This study investigated polygenic effects of the lipid metabolic pathway on cerebrospinal fluid core biomarkers, cognition,...
